Inexios Pharmaceuticals Private Limited
About Inexios Pharmaceuticals Private Limited
Data last updated:
Inexios Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Nadathur Estates Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 November 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA2006PTC041018. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Rajesh Srivathsa and Nandan Laxman Sastry.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nadathur Place 3rd Floor Plot No. 23 8th Main Road Jayanagar 3rd Block, Bangalore, Karnataka, India – 560011.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.72 Lakh, a growth of 23% compared to the previous year. For the same year it recorded a net loss of ₹1.77 Cr and EBITDA of -₹1.74 Cr. Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 22% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Inexios Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNadathur Place 3rd Floor Plot No. 23 8th Main Road Jayanagar 3rd Block, Bangalore, Karnataka, India – 560011
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Inexios Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Inexios Pharmaceuticals Private Limited
FY 2025 filings availableInexios Pharmaceuticals Private Limited reported revenue of ₹13.72 Lakh (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 23% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.74 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.77 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Inexios Pharmaceuticals Private Limited, buy the company report.
Board of directors of Inexios Pharmaceuticals Private Limited
Inexios Pharmaceuticals has 3 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Srivathsa Also directs: Nadathur Estates Private Limited, Tree Hill Estates Private Limited, Ot Services India Private Limited and 5 more | Director | 16 Apr 2018 | 8 Years 6 Months | Current |
| Nandan Laxman Sastry | Director | 16 Mar 2015 | 11 Years 7 Months | Current |
| Sriram Chakravarti | Director | 20 Sep 2021 | 5 Years 1 Months | Current |
Auditor
Inexios Pharmaceuticals Private Limited is audited by S Vijayaraghava for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S Vijayaraghava | FY 2023 | 034577 |
Shareholding
The shareholding of Inexios Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Inexios Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Inexios Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inexios Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Inexios Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
GST
Inexios Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Inexios Pharmaceuticals Private Limited, buy the company report.
Recent activity
Inexios Pharmaceuticals Private Limited has 14 board changes on record since 2007: 3 appointments and 11 cessations. The latest: Sriram Chakravarti ceased to be Additional Director on 30 Nov 2021.
5 earlier events are in the company report.
Frequently asked questions
Inexios Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 November 2006 (20+ years old) and is registered under CIN U24232KA2006PTC041018.
Inexios Pharmaceuticals has 3 current directors:
- Rajesh Srivathsa - Director
- Nandan Laxman Sastry - Director
- Sriram Chakravarti - Director
The latest financial statements of Inexios Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Inexios Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Inexios Pharmaceuticals is U24232KA2006PTC041018. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inexios Pharmaceuticals was incorporated on 23 November 2006, making it 20+ years old. It is registered with the Registrar of Companies, Bangalore.
Sriram Chakravarti ceased to be Additional Director on 30 Nov 2021. Sriram Chakravarti was appointed as Director on 20 Sep 2021. Rajesh Srivathsa ceased to be Additional Director on 14 Sep 2018. Inexios Pharmaceuticals has 14 board changes on record in total.
The registered office of Inexios Pharmaceuticals is at Nadathur Place 3rd Floor Plot No. 23 8th Main Road Jayanagar 3rd Block, Bangalore, Karnataka, India – 560011.
Inexios Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Inexios Pharmaceuticals is compliant as of 20 August 2026. The company is actively filing with the Registrar of Companies.